MARKET

DBVT

DBVT

Dbv Technologies S A
NASDAQ
24.49
+2.27
+10.22%
Opening 09:55 02/10 EST
OPEN
24.00
PREV CLOSE
22.22
HIGH
24.49
LOW
23.54
VOLUME
136.40K
TURNOVER
--
52 WEEK HIGH
26.19
52 WEEK LOW
3.820
MARKET CAP
1.24B
P/E (TTM)
-4.6684
1D
5D
1M
3M
1Y
5Y
1D
DBV Technologies nimmt am Guggenheim Securities Emerging Outlook: Biotech Summit teil
Reuters · 20h ago
DBV Technologies CEO to Present at Guggenheim Securities Emerging Outlook Biotech Summit
Reuters · 20h ago
DBV Technologies to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit
Barchart · 1d ago
Weekly Report: what happened at DBVT last week (0202-0206)?
Weekly Report · 1d ago
Kepler Capital Keeps Their Buy Rating on DBV Technologies (0QAJ)
TipRanks · 4d ago
DBV Technologies Reports 274.85 Million Shares and Voting Rights as of January 2026
Reuters · 4d ago
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of January 31, 2026
Barchart · 5d ago
Weekly Report: what happened at DBVT last week (0126-0130)?
Weekly Report · 02/02 10:21
More
About DBVT
DBV Technologies SA is a France-based clinical-stage biopharmaceutical company focused on changing the field of immunotherapy by developing a technology platform called Vaskin. The Company's therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin. It dedicates its technology to treat patients, including infants and children, suffering from severe food allergies, for whom safety is paramount, since the introduction of the offending allergen into their bloodstream can cause severe or life-threatening allergic reactions, such as anaphylactic shock. The Company's product portfolio for allergy treatments consists of Viaskin Peanut, Viaskin Milk and Viaskin Egg. The Company operates one subsidiary DBV Technologies Inc. in the United States.

Webull offers DBV Technologies SA - ADR stock information, including NASDAQ: DBVT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DBVT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DBVT stock methods without spending real money on the virtual paper trading platform.